Journal article · 2018 · Open access
Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation
Blood Advances, 2(20), 2766–2779 · Published 22 October 2018 · DOI 10.1182/bloodadvances.2018024273
In brief
“Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation” is a 2018 journal article by Luena Papa and 7 co-authors, published in Blood Advances. OpenAlex counts 45 citations as of 20 November 2026, which puts it in the top 5% of works published in 2018 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Blood Advances.
- Citations
- 45
- Most cited in
- 2020 (10)
- Field-weighted impact
- 4.30
- References
- 72
- Authors
- 8
Abstract
The limited number of hematopoietic stem cells (HSCs) in umbilical cord blood (UCB) units restricts their use for stem cell transplantation. Ex vivo treatment of UCB-CD34+ cells with valproic acid (VPA) increases the number of transplantable HSCs. In this study, we demonstrate that HSC expansion is not merely a result of proliferation of the existing stem cells but, rather, a result of a rapid reprogramming of CD34+CD90− cells into CD34+CD90+ cells, which is accompanied by limited numbers of cell divisions. Beyond this phenotypic switch, the treated cells acquire and retain a transcriptomic and mitochondrial profile, reminiscent of primary HSCs. Single and bulk RNA-seq revealed a signature highly enriched for transcripts characteristic of primary HSCs. The acquisition of this HSC signature is linked to mitochondrial remodeling accompanied by a reduced activity and enhanced glycolytic potential. These events act in concert with a modest upregulation of p53 activity to limit the levels of reactive oxygen species (ROS). Inhibition of either glycolysis or p53 activity impairs HSC expansion. This study indicates that a complex interplay of events is required for effective ex vivo expansion of UCB-HSCs.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Papa, L., Zimran, E., Djedaini, M., Ge, Y., Özbek, U., Sebra, R., Sealfon, S. C., & Hoffman, R. (2018). Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation. Blood Advances, 2(20), 2766–2779. https://doi.org/10.1182/bloodadvances.2018024273
MLA 9
Papa, Luena, et al. “Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation.” Blood Advances, vol. 2, no. 20, 2018, pp. 2766–2779. https://doi.org/10.1182/bloodadvances.2018024273.
Chicago
Papa, Luena, Eran Zimran, Mansour Djedaini, Yongchao Ge, Umut Özbek, Robert Sebra, Stuart C. Sealfon, and Ronald Hoffman. 2018. “Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation.” Blood Advances 2 (20): 2766–2779. https://doi.org/10.1182/bloodadvances.2018024273.
Harvard
Papa, L. et al. (2018) ‘Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation’, Blood Advances, 2(20), pp. 2766–2779. doi:10.1182/bloodadvances.2018024273.
IEEE
L. Papa et al., “Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation,” Blood Advances, vol. 2, no. 20, pp. 2766–2779, 2018, doi: 10.1182/bloodadvances.2018024273.
BibTeX
@article{papa2018vivo,
title = {{Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation}},
author = {Papa, Luena and Zimran, Eran and Djedaini, Mansour and Ge, Yongchao and Özbek, Umut and Sebra, Robert and Sealfon, Stuart C. and Hoffman, Ronald},
journal = {Blood Advances},
year = {2018},
volume = {2},
number = {20},
pages = {2766--2779},
doi = {10.1182/bloodadvances.2018024273},
url = {https://doi.org/10.1182/bloodadvances.2018024273}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2019 | 9 | |
| 2020 | 10 | |
| 2021 | 7 | |
| 2022 | 5 | |
| 2023 | 4 | |
| 2024 | 4 | |
| 2025 | 3 | |
| 2026 | 3 |
Its field-weighted citation impact is 4.30: it has been cited 4.30 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- hematopoietic stem cells
- ex vivo HSC expansion
- umbilical cord blood
- valproic acid
- cellular reprogramming
- mitochondrial remodeling
- p53 activation
- glycolysis
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Papa, L., Zimran, E., Djedaini, M., Ge, Y., Özbek, U., Sebra, R., Sealfon, S. C., & Hoffman, R. (2018). Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation. Blood Advances, 2(20), 2766–2779. https://doi.org/10.1182/bloodadvances.2018024273
How many times has this paper been cited?
45 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Blood Advances: sign in and open the full text from this page.
Who wrote this paper?
Luena Papa, Eran Zimran, Mansour Djedaini, Yongchao Ge, Umut Özbek, Robert Sebra, Stuart C. Sealfon, Ronald Hoffman.
What is the DOI of this paper?
10.1182/bloodadvances.2018024273, permanently at https://doi.org/10.1182/bloodadvances.2018024273. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.